Align Technology Intrinsic Value Calculation – Align Technology Stock Rises After Receiving Canadian License for Palate Expander

🌥️Trending News

Align Technology ($NASDAQ:ALGN) Inc. has seen its stock soar following the news that they received a license from Health Canada for their palate expander product. This license will make the expander available to the Canadian market, leading to increased profits for the company. Align Technology is a leading global provider of digital dental products and services. It offers a variety of orthodontic treatment solutions, including its innovative Invisalign clear aligners, which are used to treat malocclusion, or misaligned teeth.

In addition, the company provides iTero intraoral scanners, braces, and software solutions used by orthodontists and dentists to diagnose and analyze dental conditions. The Canadian license for the palate expander marks an important milestone for the company and has led to a surge of investor confidence in Align Technology’s stock. In the wake of the news, Align Technology’s stock rose more than 4 percent from its previous close. The approval of this product in the Canadian market is expected to fuel higher profits for the company, as it diversifies its product portfolio and expands into new markets. With the addition of the Canadian license for its palate expander, Align Technology has further solidified its stronghold as one of the world’s leading digital dental providers. As it continues to grow and expand, investors can look forward to continued success from the company and its stock.

Stock Price

On Thursday, ALIGN TECHNOLOGY Inc. saw its stock rise sharply after the company received a Canadian license for its palate expander product. The stock opened at $245.0 and closed at $257.0, representing an 11.1% increase from the previous closing price of 231.4. The increase was indicative of investor enthusiasm over the addition of a major new international market for ALIGN TECHNOLOGY’s product offering. The palate expander is just one of many products offered by ALIGN TECHNOLOGY, one of the world’s leading manufacturers of innovative orthodontic and digital dentistry solutions. The Canadian license, awarded by Health Canada, allows the company to expand sales to one of the world’s largest markets. This will enable ALIGN TECHNOLOGY to further capitalize on its existing growing presence in the orthodontic and digital dentistry space.

The newly approved product is expected to bring with it additional revenue opportunities for ALIGN TECHNOLOGY as well as potential cost-saving measures due to production efficiencies. This license serves as a testament to the quality and efficacy of the company’s products, further strengthening its position in the market and bolstering investor confidence in the stock. ALIGN TECHNOLOGY’s stock continues to find support from investors who are bullish on the company’s long-term prospects. The Canadian license provides a major new growth opportunity for the company and will help propel it to even greater heights in the coming years. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Align Technology. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Align Technology. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Align Technology. More…

Key Ratios Snapshot

Some of the financial key ratios for Align Technology are shown below. More…

Analysis – Align Technology Intrinsic Value Calculation

At GoodWhale, we have conducted an analysis on the well-being of ALIGN TECHNOLOGY. According to our proprietary Valuation Line, the intrinsic value of ALIGN TECHNOLOGY stock is around $440.0. This means that the current ALIGN TECHNOLOGY stock is being traded at $257.0, which is 41.6% lower than the intrinsic value. This signals that ALIGN TECHNOLOGY stock may be undervalued at this moment, making it a great opportunity to invest in this company. More…

Peers

Headquartered in San Jose, California, Align Technology was founded in 1997 and received FDA clearance for Invisalign in 1998. Align Technology went public in 2001 and today has a market capitalization of over $13 billion. The company’s competitors include QT Vascular Ltd, ViewRay Inc, and GN Store Nord A/S.

– QT Vascular Ltd ($SGX:5I0)

Ray Inc is a publicly traded company that engages in the business of providing technology solutions. Its solutions include software development, web design, and online marketing. The company’s primary focus is on small businesses. Ray Inc has a market cap of 704.13M as of 2022 and a Return on Equity of -75.17%. Ray Inc’s market cap is 704.13M, which means it has a market value of 704.13M. Ray Inc’s ROE of -75.17% means that it has a negative net income. This is likely due to the company’s expenses exceeding its revenue.

– ViewRay Inc ($NASDAQ:VRAY)

A.P. Moller – Maersk is an integrated logistics company. It operates in areas including container shipping and terminals, oil and gas, shipping and logistics, and other activities. The company has a market cap of 19.32B as of March 2021 and a return on equity of 13.56%. A.P. Moller – Maersk operates in more than 130 countries and employs around 89,000 people. The company was founded in 1904 and is headquartered in Copenhagen, Denmark.

Summary

Align Technology, Inc. (NASDAQ: ALGN) is a public company that operates a digital platform to provide clear aligners and other dental services. Recently, however, Align Technology has seen an uptick in its stock price due to a license update for its palate expander product in Canada. The company’s strong presence in the dental health services market and the promising outlook of their products has been contributing to the growing bullish sentiment among investors.